General Stability | Organism |
---|---|
inclusion of 50% glycerol prevents most of the harmful effect of freezing in imidazole buffer | Cavia porcellus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Luliberin | inhibits hydrolysis of thyroliberin competitively | Cavia porcellus | |
Peptides containing N-terminal pyroglutamyl residues | - |
Cavia porcellus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.04 | - |
Thyroliberin | - |
Cavia porcellus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
synaptosome | - |
Cavia porcellus | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Cavia porcellus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Cavia porcellus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Cavia porcellus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.3237 | - |
- |
Cavia porcellus |
Storage Stability | Organism |
---|---|
-20°C, potassium phosphate buffer, pH 7.4, stable for 6 months | Cavia porcellus |
15°C, 5% loss of activity after 7 days | Cavia porcellus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acid-thyroliberin + H2O | - |
Cavia porcellus | ? | - |
? | |
luliberin N-terminal tripeptide + H2O | pyroglutamyl-His-Trp | Cavia porcellus | ? | - |
? | |
additional information | no hydrolysis of pyroglutamyl peptides containing more than three amino acids | Cavia porcellus | ? | - |
? | |
additional information | no hydrolysis of dipeptides containing N-terminal pyroglutamic acid | Cavia porcellus | ? | - |
? | |
pyroglutamyl-His-Gly + H2O | slight | Cavia porcellus | pyroglutamate + His-Gly | - |
? | |
thyroliberin + H2O | - |
Cavia porcellus | pyroglutamic acid + His-Pro-NH2 | - |
? |